Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

A modified α-synuclein seed amplification assay in Lewy body dementia using Raman spectroscopy and machine learning analysis

Lookup NU author(s): Dr Jon Marles-WrightORCiD, Professor Alan ThomasORCiD, Professor Tiago OuteiroORCiD, Dr Ahmad Khundakar

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2025 .Background Lewy body dementias (LBD), comprising dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD), are defined by misfolded α-synuclein aggregation. Seed amplification assays (SAAs), such as RT-QuIC, enable sensitive detection of α-synuclein aggregates but typically provide binary readouts and require fluorescence labeling. Raman spectroscopy offers a label-free approach to detect subtle biochemical changes, and its diagnostic potential can be enhanced with machine learning. Objectives This proof-of-concept study aimed to evaluate whether Raman spectroscopy combined with machine learning can improve SAA-based discrimination of LBD from controls in cerebrospinal fluid (CSF). Methods We analyzed a small number of post-mortem CSF samples from pathologically confirmed DLB (n = 2), PDD (n = 2), and controls (n = 2) using a 7-day SAA. Raman spectra were collected on Days 1, 4, and 7 and analyzed using principal component analysis (PCA) and uniform manifold approximation and projection (UMAP). Results Following SAA, both PCA and UMAP distinguished combined LBD samples from controls within 24 h (Day 1), reflecting biochemical changes consistent with α-synuclein fibrillation. Spectral shifts indicated decreased α-helical content with increased β-sheet structures. No consistent separation between DLB and PDD was observed. Conclusion This preliminary study demonstrates that combining Raman spectroscopy with machine learning can enable rapid, label-free detection of disease-specific changes. Despite the very limited sample size, these findings highlight the potential of this novel workflow and strongly warrant its validation in larger cohorts.


Publication metadata

Author(s): Coles NP, Elsheikh S, Gouda A, Quesnel A, Butler L, Achadu OJ, Islam M, Kalesh K, Occhipinti A, Angione C, Marles-Wright J, Koss DJ, Thomas AJ, Outeiro TF, Filippou PS, Khundakar AA

Publication type: Article

Publication status: Published

Journal: Journal of Neuroscience Methods

Year: 2026

Volume: 425

Print publication date: 01/01/2026

Online publication date: 12/11/2025

Acceptance date: 02/11/2025

Date deposited: 01/12/2025

ISSN (print): 0165-0270

ISSN (electronic): 1872-678X

Publisher: Elsevier B.V.

URL: https://doi.org/10.1016/j.jneumeth.2025.110617

DOI: 10.1016/j.jneumeth.2025.110617

Data Access Statement: The codes generated and analyzed during the current study are openly available in the GitHub repository at https://github.com/NColes2812/RamanSpectralAnalysis

PubMed id: 41238048


Altmetrics

Altmetrics provided by Altmetric


Share